Allspring Global Investments
ANAB icon

Allspring Global Investments’s AnaptysBio ANAB Stock Holding History

Allspring Global Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,688
Closed -$38K – 2387
2024
Q1 		$38K Buy
+1,688
New +$40K ﹤0.01% 2002
2023
Q1 		– Sell
-880
Closed -$27.3K – 2773
2022
Q4 		$27.3K Sell
880
-20
-2% -$565 ﹤0.01% 2522
2022
Q3 		$22K Sell
900
-81
-8% -$1.9K ﹤0.01% 2597
2022
Q2 		$19K Sell
981
-46,282
-98% -$1.03M ﹤0.01% 2491
2022
Q1 		$1.17M Buy
47,263
+19,956
+73% +$604K ﹤0.01% 1791
2021
Q4 		$948K Buy
+27,307
New +$866K ﹤0.01% 1971

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Allspring Global Investments's ANAB Position: Q2 2024 in Review

Allspring Global Investments sold out of AnaptysBio (ANAB) in Q2 2024, closing a stake of 1,688 shares — an estimated $38K sold.

Allspring Global Investments first reported a position in ANAB in Q4 2021 and held it in 6 quarters. The position peaked at $1.17M in Q1 2022. 135 funds tracked by Wall St. Rank hold ANAB as of Q2 2024.

  • Allspring Global Investments reported no remaining AnaptysBio position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 1,688 AnaptysBio shares in Q2 2024, an estimated $38K.
  • Allspring Global Investments first reported a position in AnaptysBio in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's AnaptysBio position peaked at $1.17M in Q1 2022.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.